Literature DB >> 30008334

Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains.

Liang Qiang1, Xiaohuan Sun2, Timothy O Austin3, Hemalatha Muralidharan3, Daphney C Jean3, Mei Liu4, Wenqian Yu3, Peter W Baas5.   

Abstract

It is widely believed that tau stabilizes microtubules in the axon [1-3] and, hence, that disease-induced loss of tau from axonal microtubules leads to their destabilization [3-5]. An individual microtubule in the axon has a stable domain and a labile domain [6-8]. We found that tau is more abundant on the labile domain, which is inconsistent with tau's proposed role as a microtubule stabilizer. When tau is experimentally depleted from cultured rat neurons, the labile microtubule mass of the axon drops considerably, the remaining labile microtubule mass becomes less labile, and the stable microtubule mass increases. MAP6 (also called stable tubule-only polypeptide), which is normally enriched on the stable domain [9], acquires a broader distribution across the microtubule when tau is depleted, providing a potential explanation for the increase in stable microtubule mass. When MAP6 is depleted, the labile microtubule mass becomes even more labile, indicating that, unlike tau, MAP6 is a genuine stabilizer of axonal microtubules. We conclude that tau is not a stabilizer of axonal microtubules but is enriched on the labile domain of the microtubule to promote its assembly while limiting the binding to it of genuine stabilizers, such as MAP6. This enables the labile domain to achieve great lengths without being stabilized. These conclusions are contrary to tau dogma.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MAP6; axon; microtubule; microtubule stability; neuron; tau

Mesh:

Substances:

Year:  2018        PMID: 30008334     DOI: 10.1016/j.cub.2018.05.045

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  61 in total

Review 1.  Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.

Authors:  Fred Yeboah; Tae-Eun Kim; Anke Bill; Ulf Dettmer
Journal:  Neurobiol Dis       Date:  2019-07-24       Impact factor: 5.996

Review 2.  Tau: It's Not What You Think.

Authors:  Peter W Baas; Liang Qiang
Journal:  Trends Cell Biol       Date:  2019-03-28       Impact factor: 20.808

Review 3.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

4.  Drosophila Tau Negatively Regulates Translation and Olfactory Long-Term Memory, But Facilitates Footshock Habituation and Cytoskeletal Homeostasis.

Authors:  Katerina Papanikolopoulou; Ilianna G Roussou; Jean Y Gouzi; Martina Samiotaki; George Panayotou; Luca Turin; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

5.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

6.  MAP7 Prevents Axonal Branch Retraction by Creating a Stable Microtubule Boundary to Rescue Polymerization.

Authors:  Stephen R Tymanskyj; Le Ma
Journal:  J Neurosci       Date:  2019-08-07       Impact factor: 6.167

Review 7.  Elucidating Tau function and dysfunction in the era of cryo-EM.

Authors:  Guy Lippens; Benoît Gigant
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

Review 8.  Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies.

Authors:  Che-Wei Chang; Eric Shao; Lennart Mucke
Journal:  Science       Date:  2021-02-26       Impact factor: 47.728

9.  Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.

Authors:  Mirta Boban; Mirjana Babić Leko; Terezija Miškić; Patrick R Hof; Goran Šimić
Journal:  J Neurosci Methods       Date:  2018-09-29       Impact factor: 2.390

Review 10.  The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.

Authors:  Sanjib Guha; Gail V W Johnson; Keith Nehrke
Journal:  Mol Neurobiol       Date:  2020-08-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.